ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for investors and analysts on Monday, October 22, 2018, during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, TX.
CLEVELAND, PRNewswire/ -- ViewRay , Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for investors and analysts on Monday, October 22, 2018, during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, TX. The meeting will include a brief company update from Scott Drake, President and Chief Executive Officer of ViewRay, followed by presentations from Louis B. Harrison, M.D., FASTRO, Chair and Senior Member, Department of Radiation Oncology at Moffitt Cancer Center and Michael L. Steinberg, M.D., Professor and Chair, Department of Radiation Oncology at the David Geffen School of Medicine at UCLA. Dr. Harrison will discuss the opportunity for MRI-guided radiotherapy in the treatment of cancer and its potential contribution to personalizing radiation therapy. Dr. Steinberg will share UCLA's experience with MRI-guided radiotherapy using the MRIdian System, including adaptive radiation therapy, emerging functional imaging capabilities of the system, and economic modeling leading to cost effectiveness. Breakfast will be served at the meeting.
As space is limited, please RSVP to Kaitlyn Brosco at kbrosco@theruthgroup.com if you wish to attend the live event. An audio webcast of the presentation will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 7 days after the date of the presentation. About ViewRay Forward Looking Statements:
SOURCE ViewRay, Inc. |
||||||||||
Company Codes: NASDAQ-NMS:VRAY |